Zambon SpA clinical trials
The registry lists 24 studies whose lead sponsor is Zambon SpA or one of 1 company grouped under it. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.
Our grouping of 2 registry names, not the registry’s. See them and correct one ↓
- 24studies on the registry
- 0open to participants now
What it is testing
The drugs Zambon SpA’s studies test, most studies first; none is open now — 9 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- safinamide2 in phase 30 open · 5
- Acetylcysteine2 in phase 30 open · 4
- Cyclosporine3 in phase 30 open · 4
- 0 open · 2
- 0 open · 2
- 0 open · 2
- colistinmethanesulfonic acid1 in phase 30 open · 1
- 0 open · 1
- 0 open · 1
All 24 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 919
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started; 1 started before 2012. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Zambon SpA.
- Zambon SpA23 studiesSame company
Something wrong?
- Zambon SAU1 study →Regional office
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 24 of 24.
- Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.TerminatedNCT03460704Phase 3
- Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic PatientsCompletedNCT02227394Phase 2
- A Retrospective Chart Review Study of Patients With CLAD-BOS Post Lung TransplantationCompletedNCT06503770
- Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)TerminatedNCT04039347Phase 3
- Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)CompletedNCT03656926Phase 3
- Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)CompletedNCT03657342Phase 3
- A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus SecretionsCompletedNCT03843541Phase 3
- An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PDCompletedNCT03994328
- A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of LevodopaCompletedNCT03881371Phase 3
- Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)CompletedNCT03093974Phase 3
- A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4)TerminatedNCT04107675Phase 2
- Effect of Safinamide on Parkinson's Disease Related Chronic PainCompletedNCT03841604Phase 4
- A Single and Multiple Dose Study to Assess How the Drug Enters, Moves Through and Exits the Body, Safety and Tolerability of Safinamide in Healthy Adult Chinese VolunteersCompletedNCT03887221Phase 1
- Clinical Study to Evaluate Z7200 Pharmacokinetics ProfileCompletedNCT02631941Phase 1
- A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy VolunteersCompletedNCT02237508Phase 1
- Durolane SJ for Treatment of RhizarthrosisCompletedNCT02676284Not applicable
Sponsor listed in the registry: Zambon SAU
- Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic SubjectsCompletedNCT04229303Phase 1
- Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC)CompletedNCT02265224Phase 1
- Safinamide for Multiple System Atrophy (MSA)CompletedNCT03753763Phase 2
- A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Multiple Intravenous Doses of N-acetylcysteine (NAC) in Chinese Healthy VolunteersCompletedNCT03881163Phase 1
- Safinamide for Levodopa-induced Dyskinesia (PD-LID)WithdrawnNCT03987750Phase 3
- Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal DrynessCompletedNCT02994342Not applicable
- Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy VolunteersCompletedNCT02495831Phase 1
- Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00639496Phase 3